Regeneron Pharmaceuticals
REGN
#288
Rank
S$98.66 B
Marketcap
S$930.92
Share price
-0.61%
Change (1 day)
-10.40%
Change (1 year)

Regeneron Pharmaceuticals (REGN) - Total debt

Total debt on the balance sheet as of September 2025 : S$3.50 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's total debt is S$3.50 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Regeneron Pharmaceuticals - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31S$3.67 B2.98%
2023-12-31S$3.56 B-1.43%
2022-12-31S$3.62 B-0.77%
2021-12-31S$3.64 B2.34%
2020-12-31S$3.56 B270.53%
2019-12-31S$0.96 B-0.56%
2018-12-31S$0.96 B2.87%
2017-12-31S$0.94 B35.13%
2016-12-31S$0.69 B35.64%
2015-12-31S$0.51 B-15.12%
2014-12-31S$0.60 B-5.4%
2013-12-31S$0.63 B14.31%
2012-12-31S$0.55 B-0.85%
2011-12-31S$0.56 B173.62%
2010-12-31S$0.20 B34.68%
2009-12-31S$0.15 B2001.41%
2008-12-31S$7.28 M-97.47%
2007-12-31S$0.28 B-6.16%
2006-12-31S$0.30 B-7.9%
2005-12-31S$0.33 B2.06%
2004-12-31S$0.32 B-10.18%
2003-12-31S$0.36 B4.6%
2002-12-31S$0.34 B-6.47%
2001-12-31S$0.37 B7890.97%
2000-12-31S$4.64 M-31.93%
1999-12-31S$6.82 M-1.55%
1998-12-31S$6.93 M-26.56%
1997-12-31S$9.44 M-22.46%
1996-12-31S$12.17 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Amgen
AMGN
S$70.73 B 1,917.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$1.69 B-51.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$8.54 B 143.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$59.34 B 1,592.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$41.49 B 1,083.59%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
S$33.08 B 843.68%๐Ÿ‡ซ๐Ÿ‡ท France